Articles dans des revues avec comité de lecture (368)
  1. 166. Meuleman, N., Vanhaelen, G., Tondreau, T., Lewalle, P., Kwan, J., Bennani, J., Martiat, P., Lagneaux, L., & Bron, D. (2008). Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica, 93(1), e11-e13. doi:10.3324/haematol.11802
  2. 167. Meuleman, N., Tondreau, T., Vanhaelen, G., Lagneaux, L., & Bron, D. (2008). Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica, 93(5), e48.
  3. 168. Meuleman, N., Vanhaelen, G., Tondreau, T., Lewalle, P., Kwan, J., Bennani, J., Martiat, P., Lagneaux, L., & Bron, D. (2008). Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stromal Cell (MSC) infusion for the Treatment of Metachromatic Leukodystrophy (MLD): A case report. Haematologica, 93(1), 48.
  4. 169. Lagneaux, L., Gillet, N., Stamatopoulos, B., Delforge, A., Dejeneffe, M., Massy, M., Meuleman, N., Kentos, A., Martiat, P., Willems, L., & Bron, D. (2007). Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Experimental hematology, 35(10), 1527-1537. doi:10.1016/j.exphem.2007.06.014
  5. 170. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Duvillier, H., Massy, M., Martiat, P., Bron, D., & Lagneaux, L. (2007). Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clinical chemistry, 53(10), 1757-1766. doi:10.1373/clinchem.2007.089326
  6. 171. Vanheste, S., Vereecken, P., Lambermont, M., Heenen, M., & Bron, D. (2007). La photochimiothérapie extracorporelle: revue de son mode d'action et de ses indications. Revue médicale de Bruxelles, 28(5), 445-451.
  7. 172. Meuleman, N., Ahmad, I., Duvillier, H., Lemort, M., Bennani, J., Martiat, M., Lagneaux, L., & Bron, D. (2006). Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report. European journal of haematology, 77(6), 523-526. doi:10.1111/j.0902-4441.2006.t01-1-EJH2498.x
  8. 173. Ngirabacu, M.-C., Ravoet, C., Dargent, J.-L., Meuleman, N., Ahmad, I., Ysebrant, L., Bennani, J., André, M. J., & Bron, D. (2006). Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis. Haematologica, 91(12 Suppl), ECR53.
  9. 174. Meuleman, N., Tondreau, T., Delforge, A., Dejeneffe, M., Massy, M., Libertalis, M., Bron, D., & Lagneaux, L. (2006). Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. European journal of haematology, 76(4), 309-316. doi:10.1111/j.1600-0609.2005.00611.x
  10. 175. Van Belle, S., Paridaens, R., Evers, G., Kerger, J., Bron, D., Foubert, J., Ponnet, G., Vander Steichel, D., Heremans, C., & Rosillon, D. (2005). Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: A retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia, 19(12), 2304-2312. doi:10.1038/sj.leu.2403967
  11. 176. Zwierzina, H., Suciu, S., Loeffler, J. S., Neuwirtova, R., Fenaux, P., Beksac, M. S., Harousseau, J.-L., Nuessler, V., Cermak, J., Solbu, G., Willemze, R., De Witte, T., Amadori, S., Stryckmans, P., Bron, D., Louwagie, A., Selleslag, D., Peetermans, M., Berneman, Z. N., Coiffier, B., Thyss, A., Bourhis, J., Fiere, D., Zittoun, R., Marie, J. P., Maraninchi, D., Baumelou, E., Lowenberg, B., Sonnenveld, P., Gerhartz, H., Ribeiro, M. M., Ben-Bassat, I., Labar, B., & Dardenne, M. (2005). Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group. Leukemia, 19(11), 1929-1933. doi:10.1038/sj.leu.2403934
  12. 177. Tondreau, T., Meuleman, N., Delforge, A., Dejeneffe, M., Leroy, R., Massy, M., Mortier, C., Bron, D., & Lagneaux, L. (2005). Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem cells, 23(8), 1105-1112. doi:10.1634/stemcells.2004-0330
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>